All In MedTech

Device Trial Radar · NCT06169683

Lyric4 Outcomes Evaluation

Evaluation of Daily- and Extended-wear Hearing Instruments

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

28

Actual

Start

Nov 10, 2023

Primary completion

Dec 15, 2023

Study completion Dec 15, 2023

Sponsor

Lead sponsor
Sonova AGNot on our public-company list
Sponsor type
Industry
First posted
Dec 13, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical investigation is to obtain feedback on Lyric4 device updates within a cohort of experienced adult Lyric hearing instrument users. The main question it aims to answer is: • Do device updates cause a change in Lyric patient experience? Participants will be asked to complete questionnaires about their past experience with Lyric, as well as their experience with Lyric during the study period. They will also be asked to undergo aided audiometric testing with Lyric devices.

Conditions

  • Hearing Loss

Interventions

  • Lyric4Device

    Lyric4 Hearing instrument use

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Aided Audiometric TestingTime frame: From enrollment to the end of the study period, approximately one month.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Sonova Silicon Valley

    Fremont, California

  • Triangle Hearing Services

    Cary, North Carolina

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.